Cargando…

Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease

BACKGROUND: Tuberculosis (TB) is common among HIV-infected individuals in many resource-limited countries and has been associated with poor survival. We evaluated morbidity and mortality among individuals first starting antiretroviral therapy (ART) with concurrent active TB or other AIDS-defining di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Périssé, André R. S., Smeaton, Laura, Chen, Yun, La Rosa, Alberto, Walawander, Ann, Nair, Apsara, Grinsztejn, Beatriz, Santos, Breno, Kanyama, Cecilia, Hakim, James, Nyirenda, Mulinda, Kumarasamy, Nagalingeswaran, Lalloo, Umesh G., Flanigan, Timothy, Campbell, Thomas B., Hughes, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877069/ https://www.ncbi.nlm.nih.gov/pubmed/24391801 http://dx.doi.org/10.1371/journal.pone.0083643

Ejemplares similares

Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial
por: Safren, Steven A., et al.
Publicado: (2014)

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
por: Campbell, Thomas B., et al.
Publicado: (2012)

Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
por: Salata, Robert A., et al.
Publicado: (2023)

A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings
por: Erlandson, Kristine M., et al.
Publicado: (2015)

Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207
por: Hitti, Jane, et al.
Publicado: (2014)

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?
por: Kumarasamy, N., et al.
Publicado: (2011)

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
por: Dharan, Nila J., et al.
Publicado: (2019)

C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings
por: Tenforde, Mark W., et al.
Publicado: (2015)

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
por: Balagopal, Ashwin, et al.
Publicado: (2016)

Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2018)

Challenges of diabetes in elderly TB patients
por: Jali, M.V., et al.
Publicado: (2022)

Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)
por: Srasuebkul, Preeyaporn, et al.
Publicado: (2007)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
por: Palumbo, Philip J., et al.
Publicado: (2017)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Immediate start of antiretroviral, why not?
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2018)

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB
por: Chakaya, Jeremiah, et al.
Publicado: (2022)

Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India - the HIVIND study protocol
por: De Costa, Ayesha, et al.
Publicado: (2010)

837 Early Goal Directed Therapy for Acute Bacterial Meningitis in Malawian Adults
por: Wall, Emma, et al.
Publicado: (2014)

Factors associated with suboptimal adherence to antiretroviral therapy in Asia
por: Jiamsakul, Awachana, et al.
Publicado: (2014)

Impact of COVID-19 on people living with HIV: A review
por: Prabhu, Sandeep, et al.
Publicado: (2020)

Start concurrent: an introduction to problem solving in Java with a focus on concurrency, 2014
por: Wittman, Barry, et al.
Publicado: (2014)

Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial
por: Avihingsanon, Anchalee, et al.
Publicado: (2022)

Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
por: Piggott, Damani A., et al.
Publicado: (2011)

When to start antiretroviral therapy: as soon as possible
por: Franco, Ricardo A, et al.
Publicado: (2013)

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
por: Makurumidze, Richard, et al.
Publicado: (2020)

Improvement in Muscular Strength in HIV-Infected Individuals Receiving Antiretroviral Therapy
por: Sookan, Takshita, et al.
Publicado: (2019)

TB testing in HIV-positive patients prior to antiretroviral treatment
por: Spooner, E., et al.
Publicado: (2022)

Gender differences in oral lesions among persons with HIV disease in Southern India
por: Rao, Umadevi Krishna Mohan, et al.
Publicado: (2012)

Implications in the quantification of SARS-CoV2 copies in concurrent nasopharyngeal swabs, whole mouth fluid and respiratory droplets
por: Kannian, Priya, et al.
Publicado: (2021)

Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium
por: Jesson, Julie, et al.
Publicado: (2020)

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial
por: Post, Frank A, et al.
Publicado: (2018)

The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomized trial
por: Howard, Andrea A., et al.
Publicado: (2016)

Serum Phosphate Predicts Early Mortality in Adults Starting Antiretroviral Therapy in Lusaka, Zambia: A Prospective Cohort Study
por: Heimburger, Douglas C., et al.
Publicado: (2010)

Antiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts
por: Granich, Reuben, et al.
Publicado: (2011)

Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria
por: Odume, B., et al.
Publicado: (2017)

When Should Children with HIV Infection Be Started on Antiretroviral Therapy?
por: Welch, Steven B, et al.
Publicado: (2008)

When should antiretroviral therapy be started in HIV-positive persons?
por: Sabin, Caroline A
Publicado: (2010)

Predicting virological decay in patients starting combination antiretroviral therapy
Publicado: (2016)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fballaapk8tb0ifb6d5d0dinv9